Chris Picardo
Director/Board Member at Modulus Therapeutics, Inc.
Chris Picardo active positions
| Companies | Position | Start | End |
|---|---|---|---|
Modulus Therapeutics, Inc.
 Modulus Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Modulus Therapeutics, Inc. is a company dedicated to discovering cell therapy solutions for patients. The company is based in Seattle, WA. The company uses rapid prototyping and generative design to accelerate discovery and optimize cell therapies to meet therapeutic design goals. The company's platform offers a unique opportunity to leverage machine learning to maximize efficacy through modular design. Modulus envisions a world where cancer is no longer a life-threatening disease, and they are dedicated to transforming the future of cancer therapy through design-driven therapeutics. Modulus Therapeutics was founded in 2020 by Max Darnell and Bryce Daines. Max Darnell has been the CEO since 2020. | Director/Board Member | - | - |
| Life Science Washington | Director/Board Member | 10/01/2022 | - |
Career history of Chris Picardo
Training of Chris Picardo
| Williams College | Undergraduate Degree |
Statistics
International
| United States | 4 |
Operational
| Director/Board Member | 2 |
| Undergraduate Degree | 1 |
Sectoral
| Consumer Services | 2 |
| Commercial Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Private companies | 2 |
|---|---|
Modulus Therapeutics, Inc.
Modulus Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Modulus Therapeutics, Inc. is a company dedicated to discovering cell therapy solutions for patients. The company is based in Seattle, WA. The company uses rapid prototyping and generative design to accelerate discovery and optimize cell therapies to meet therapeutic design goals. The company's platform offers a unique opportunity to leverage machine learning to maximize efficacy through modular design. Modulus envisions a world where cancer is no longer a life-threatening disease, and they are dedicated to transforming the future of cancer therapy through design-driven therapeutics. Modulus Therapeutics was founded in 2020 by Max Darnell and Bryce Daines. Max Darnell has been the CEO since 2020. | Commercial Services |
| Life Science Washington |
- Stock Market
- Insiders
- Chris Picardo
- Experience
